As of 2008, treatments of<unk> s depends on the severity of the complication. No treatment is available for anencephaly and infants usually do not survive more than a few hours. Aggressive surgical management has improved survival and the functions of infants with spina bifida, meningoceles and mild myelomeningoceles. The success of surgery often depends on the amount of brain tissue involved in the encephalocele. The goal of treatment for<unk> s is to allow the individual to achieve the highest level of function and independence. Fetal surgery in utero before 26 weeks gestation has been performed with some hope that there is benefit to the outcome including a reduction in Arnold–Chiari malformation and thereby decreases the need for a ventriculoperitoneal shunt but the procedure is very high risk for both mother and baby and is considered extremely invasive with questions that the positive outcomes may be due to ascertainment bias and not true benefit. Further, this surgery is not a cure for all problems associated with a<unk> . Other areas of research include tissue engineering and stem cell therapy but this research has not been used in humans.
Neural tube defect
Birth defect
Congenital limb deformities
Craniofacial abnormality
Vocal cord dysfunction
Neonatal sepsis
Perinatal asphyxia
Renal hypoplasia